These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9449287)

  • 1. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1998 Jan; 42(1):194-6. PubMed ID: 9449287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia.
    Roblin PM; Montalban G; Hammerschlag MR
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1588-9. PubMed ID: 7979292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
    Harris JA; Kolokathis A; Campbell M; Cassell GH; Hammerschlag MR
    Pediatr Infect Dis J; 1998 Oct; 17(10):865-71. PubMed ID: 9802626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Roblin PM
    Int J Antimicrob Agents; 2000 Jul; 15(2):149-52. PubMed ID: 10854812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae.
    Gnarpe J; Eriksson K; Gnarpe H
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1843-5. PubMed ID: 8843291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
    Roblin PM; Kohlhoff SA; Parker C; Hammerschlag MR
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1358-9. PubMed ID: 20038627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Reznik T; Roblin PM; Ramirez J; Summersgill J; Bukofzer S
    J Antimicrob Chemother; 2003 Apr; 51(4):1025-8. PubMed ID: 12654764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis.
    Wolf K; Malinverni R
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1491-3. PubMed ID: 10348778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
    Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
    Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin in treatment of patients with asthma and C. Pneumoniae infection.
    Dokic D; Poposki B; Karkinski D
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(2):71-7. PubMed ID: 24296633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Roblin PM
    Antimicrob Agents Chemother; 2000 May; 44(5):1409. PubMed ID: 10819727
    [No Abstract]   [Full Text] [Related]  

  • 12. Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: report of a case.
    Wang JH; Wang JH; Liu YC; Chen YS; Yen MY; Wann SR; Cheng DL
    J Formos Med Assoc; 1994 Jul; 93(7):642-4. PubMed ID: 7866068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology and treatment of community-acquired pneumonia in ambulatory children.
    Wubbel L; Muniz L; Ahmed A; Trujillo M; Carubelli C; McCoig C; Abramo T; Leinonen M; McCracken GH
    Pediatr Infect Dis J; 1999 Feb; 18(2):98-104. PubMed ID: 10048679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1515-6. PubMed ID: 9624507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae pneumonia: role of new macrolides.
    Blasi F; Cosentini R; Tarsia P; Camusso L; Campi E; Arosio C; Allegra L
    J Chemother; 1995 Nov; 7 Suppl 4():117-8. PubMed ID: 8904128
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis.
    Malinverni R; Kuo CC; Campbell LA; Lee A; Grayston JT
    Antimicrob Agents Chemother; 1995 Jan; 39(1):45-9. PubMed ID: 7695327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
    Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
    J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.
    Hammerschlag MR; Qumei KK; Roblin PM
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1573-4. PubMed ID: 1324650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
    Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
    Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.